OBI Pharma, Inc.
OBI Pharma, Inc.
≈ 1 min read
OBI Pharma, Inc.. encyclopegia.org, snapshot enwiki-001359628412. /a/obi-pharma-inc
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
OBI Pharma, Inc. ( ) ( ) is a bio-pharmaceutical company, based in Nangang District, Taipei, Taiwan. In 2018 it announced that its drug, OBI-3424, has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of Hepatocellular Carcinoma (HCC).
References
Optimer Pharmaceuticals
Text derived from https://en.wikipedia.org/w/index.php?oldid=1359628412 under CC BY-SA 4.0; modifications have been made.